Worldwide, more Hepatitis C patients have been treated with generic medication than the overpriced branded medication.

Over 90% of patients who have treatment will achieve SVR12 and the data has been presented at the International Liver Congress.


Welcome, Guest
Username: Password: Remember me
Login With :

TOPIC: Innovation award for Prof Ed Gane

Innovation award for Prof Ed Gane 2 months 4 weeks ago #23811

  • Hazel
  • Hazel's Avatar
  • Offline
  • Elite Member
  • Posts: 247
  • Thank you received: 954
  • Karma: 9
Hi all,
I was :woohoo: to see this, in NZ we have Prof Gane to thank for Gastro guidelines and for the guidance of the NZ Hep Foundation that tell clinicians and patients about their generic options, with a link to FixhepC, as we have the unusual situation of only having v-pak for genotype 1 here. This is pretty amazing- pragmatic and fair, our official information is- use generics for now at least if you need to. I can say, loosely accurate, the NZ govt recommends FixhepC, which is a powerful endorsement in convincing people/organisations/govts that they can see how medically conventional a pathway it is now.
So congratulations Prof Gane
Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan 40 down to 22 by 29/3/16- 10/16 dropped to 9.5, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716
The administrator has disabled public write access.
The following user(s) said Thank You: James-Freeman-facebook, Chapel, coral, Paul-Jarman-facebook, Gaj
Time to create page: 0.149 seconds